| Evaluation of cancer risk in patients with periodontal diseases DC Güven, Ö Dizdar, AC Akman, AE BERKER, E Yekedüz, F Ceylan, ... Turkish journal of medical sciences 49 (3), 826-831, 2019 | 36 | 2019 |
| Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy DC Guven, MS Aksun, TK Sahin, OH Aktepe, HC Yildirim, H Taban, ... Supportive Care in Cancer 29, 5417-5423, 2021 | 23 | 2021 |
| Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience E Bilgin, F Ceylan, E Duran, B Farisoğullari, EÇ Bölek, GK Yardimci, ... Turkish journal of medical sciences 51 (1), 297-308, 2021 | 20 | 2021 |
| The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study DC Guven, R Acar, E Yekeduz, I Bilgetekin, NK Baytemur, C Erol, ... Current problems in cancer 45 (6), 100760, 2021 | 18 | 2021 |
| Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic DC Guven, F Ceylan, IY Cakir, E Cesmeci, B Sayinalp, B Yesilyurt, ... Supportive Care in Cancer 29, 4159-4164, 2021 | 8 | 2021 |
| Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case report DC Guven, S Kilickap, HC Yildirim, F Ceylan, O Bas, O Dizdar Journal of Oncology Pharmacy Practice 27 (5), 1281-1283, 2021 | 6 | 2021 |
| Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy TK Sahin, Y Ozbay, AY Altunbulak, HI Altunbulak, MR Onur, F Ceylan, ... International Journal of Clinical Oncology 29 (6), 822-831, 2024 | 5 | 2024 |
| Knowledge, Attitudes, and Perception towards COVID-19 Vaccination among the Adult Population: A Cross-Sectional Study in Turkey. Vaccines. 2022; 10 (2): 278 MC Sonmezer, TK Sahin, E Erul, FS Ceylan, MY Hamurcu, N Morova, ... PubMed Abstract| Publisher Full Text| Free Full Text| Reference Source, 0 | 5 | |
| The prognostic and predictive role of class III β-Tubulin and hENT1 expression in patients with advanced pancreatic ductal adenocarcinoma TK Sahin, A Isik, DC Guven, F Ceylan, B Babaoglu, A Akyol, S Yalcin, ... Pancreatology 24 (2), 279-288, 2024 | 2 | 2024 |
| High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach H BÖLEK, S Cetik, F Ceylan, E BÖLEK, O UYAROĞLU, M TANRIÖVER Acta Medica 54 (2), 2023 | 2 | 2023 |
| A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review SC Efil, B Bilgin, F Ceylan, H Karakaş, İ Karahan, SN Özsan, H Kosku, ... Journal of Oncology Pharmacy Practice 30 (7), 1214-1239, 2024 | 1 | 2024 |
| Is fibroblast growth factor 11 (FGF11) a predictive marker for breast cancer? SA Esen, S Karabulut, M Buyukaksoy, GK Cevik, F Ceylan, B Civelek, ... Medicine 103 (13), e37656, 2024 | 1 | 2024 |
| Comparison of two alternative sequences with cabazitaxel and 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A retrospective multicenter study (LuCaS) H Bolek, SC Yazgan, F Ceylan, J Esteban-Villarrubia, C Arslan, T Kuş, ... European Journal of Cancer 217, 115226, 2025 | | 2025 |
| Palliative Radiotherapy in Metastatic Breast Cancer Patients on CDK4/6 Inhibitors: Safety Analysis F Ceylan, M Mehdiyev, B Bilgin, AK Tenekeci, B Yalçın, MB Akıncı, ... Cancers 17 (3), 424, 2025 | | 2025 |
| Large Unstained Cells: A Predictive Biomarker for Recurrence and Survival in Resected Gastric Cancer F Ceylan, AK Tenekeci, B Bilgin, MAN Şendur, M Hızal, FT Köş, DŞ Dede Medicina 61 (2), 208, 2025 | | 2025 |
| Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer F Ceylan, M Mehdiyev, DŞ Dede, SC Efil, AK Tenekeci, B Bilgin, Ş Yücel, ... Journal of Clinical Medicine 14 (1), 173, 2024 | | 2024 |
| An updated overview of K-RAS G12C inhibitors in advanced stage non-small cell lung cancer AK Tenekeci, AA Unal, F Ceylan, MA Nahit Sendur Future Oncology 20 (37), 3019-3038, 2024 | | 2024 |
| Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study S Sekmek, I Karahan, G Ucar, F Ceylan, D Bayram, I Seven, H Bölek, ... Clinical and Translational Oncology 26 (8), 1878-1885, 2024 | | 2024 |
| Erken Evre ve Yaygın Evre Küçük Hücreli Akciğer Kanserinde Güncel Tedavi Yaklaşımları F CEYLAN, MAN ŞENDUR Turkiye Klinikleri Medical Oncology-Special Topics 17 (2), 74-84, 2024 | | 2024 |
| Role of Immunotherapy for Small Cell Lung Cancer F CEYLAN, MAN ŞENDUR Turkiye Klinikleri Medical Oncology-Special Topics 17 (1), 44-51, 2024 | | 2024 |
